The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Diabetes Care Drugs Market Research Report 2025

Global Diabetes Care Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1716602

No of Pages : 107

Ask Your Query
Synopsis
Diabetes is a group of metabolic diseases characterized by hyperglycemia. HYPERGLYCEMIA is caused by defective insulin secretion or impaired biological function, or both. The long-term existence of high blood sugar in diabetes leads to chronic damage and dysfunction of various tissues, especially eyes, kidneys, heart, blood vessels and nerves.Diabetes care drugs are used to treat diabetes.
The global Diabetes Care Drugs market was valued at US$ 71520 million in 2023 and is anticipated to reach US$ 103030 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diabetes Care Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Care Drugs.
Report Scope
The Diabetes Care Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Care Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Care Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Sanofi
Eli Lilly
Biocon
AstraZeneca
Bristol Myers Squibb
Boehringer Ingelheim
Mylan
Pfizer
Johnson & Johnson
Merck
Novartis
Astellas
Teva
Bayer
Ganlee
Ginwa
MSD
Hisun Pharmacy
Huadong Medicine
Jumpcan Pharmacy
KELUN
North China Pharmaceutical Group Corporation
Taloph
Tianan Pharmaceutical
Tonghua DongBao
Wanbang Biopharmaceuticals
Takeda
SHIJIAZHUANG YILING PHARMACEUTICAL
Guangzhou Baiyun Mountain
Segment by Type
Oral Anti-diabetic Drugs
Insulins
Non-insulin Injectable Drugs
Other
Segment by Application
Hospital
Medical Research Institute
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Care Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Care Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Anti-diabetic Drugs
1.2.3 Insulins
1.2.4 Non-insulin Injectable Drugs
1.2.5 Other
1.3 Market by Application
1.3.1 Global Diabetes Care Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Research Institute
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Care Drugs Market Perspective (2019-2030)
2.2 Diabetes Care Drugs Growth Trends by Region
2.2.1 Global Diabetes Care Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diabetes Care Drugs Historic Market Size by Region (2019-2024)
2.2.3 Diabetes Care Drugs Forecasted Market Size by Region (2025-2030)
2.3 Diabetes Care Drugs Market Dynamics
2.3.1 Diabetes Care Drugs Industry Trends
2.3.2 Diabetes Care Drugs Market Drivers
2.3.3 Diabetes Care Drugs Market Challenges
2.3.4 Diabetes Care Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Care Drugs Players by Revenue
3.1.1 Global Top Diabetes Care Drugs Players by Revenue (2019-2024)
3.1.2 Global Diabetes Care Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Diabetes Care Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diabetes Care Drugs Revenue
3.4 Global Diabetes Care Drugs Market Concentration Ratio
3.4.1 Global Diabetes Care Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Care Drugs Revenue in 2023
3.5 Diabetes Care Drugs Key Players Head office and Area Served
3.6 Key Players Diabetes Care Drugs Product Solution and Service
3.7 Date of Enter into Diabetes Care Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Care Drugs Breakdown Data by Type
4.1 Global Diabetes Care Drugs Historic Market Size by Type (2019-2024)
4.2 Global Diabetes Care Drugs Forecasted Market Size by Type (2025-2030)
5 Diabetes Care Drugs Breakdown Data by Application
5.1 Global Diabetes Care Drugs Historic Market Size by Application (2019-2024)
5.2 Global Diabetes Care Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diabetes Care Drugs Market Size (2019-2030)
6.2 North America Diabetes Care Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Diabetes Care Drugs Market Size by Country (2019-2024)
6.4 North America Diabetes Care Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetes Care Drugs Market Size (2019-2030)
7.2 Europe Diabetes Care Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Diabetes Care Drugs Market Size by Country (2019-2024)
7.4 Europe Diabetes Care Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Care Drugs Market Size (2019-2030)
8.2 Asia-Pacific Diabetes Care Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Diabetes Care Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Diabetes Care Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetes Care Drugs Market Size (2019-2030)
9.2 Latin America Diabetes Care Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Diabetes Care Drugs Market Size by Country (2019-2024)
9.4 Latin America Diabetes Care Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Care Drugs Market Size (2019-2030)
10.2 Middle East & Africa Diabetes Care Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Diabetes Care Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Diabetes Care Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Detail
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Diabetes Care Drugs Introduction
11.1.4 Novo Nordisk Revenue in Diabetes Care Drugs Business (2019-2024)
11.1.5 Novo Nordisk Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Diabetes Care Drugs Introduction
11.2.4 Sanofi Revenue in Diabetes Care Drugs Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Diabetes Care Drugs Introduction
11.3.4 Eli Lilly Revenue in Diabetes Care Drugs Business (2019-2024)
11.3.5 Eli Lilly Recent Development
11.4 Biocon
11.4.1 Biocon Company Detail
11.4.2 Biocon Business Overview
11.4.3 Biocon Diabetes Care Drugs Introduction
11.4.4 Biocon Revenue in Diabetes Care Drugs Business (2019-2024)
11.4.5 Biocon Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Diabetes Care Drugs Introduction
11.5.4 AstraZeneca Revenue in Diabetes Care Drugs Business (2019-2024)
11.5.5 AstraZeneca Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Detail
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Diabetes Care Drugs Introduction
11.6.4 Bristol Myers Squibb Revenue in Diabetes Care Drugs Business (2019-2024)
11.6.5 Bristol Myers Squibb Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Detail
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim Diabetes Care Drugs Introduction
11.7.4 Boehringer Ingelheim Revenue in Diabetes Care Drugs Business (2019-2024)
11.7.5 Boehringer Ingelheim Recent Development
11.8 Mylan
11.8.1 Mylan Company Detail
11.8.2 Mylan Business Overview
11.8.3 Mylan Diabetes Care Drugs Introduction
11.8.4 Mylan Revenue in Diabetes Care Drugs Business (2019-2024)
11.8.5 Mylan Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Diabetes Care Drugs Introduction
11.9.4 Pfizer Revenue in Diabetes Care Drugs Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Diabetes Care Drugs Introduction
11.10.4 Johnson & Johnson Revenue in Diabetes Care Drugs Business (2019-2024)
11.10.5 Johnson & Johnson Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Diabetes Care Drugs Introduction
11.11.4 Merck Revenue in Diabetes Care Drugs Business (2019-2024)
11.11.5 Merck Recent Development
11.12 Novartis
11.12.1 Novartis Company Detail
11.12.2 Novartis Business Overview
11.12.3 Novartis Diabetes Care Drugs Introduction
11.12.4 Novartis Revenue in Diabetes Care Drugs Business (2019-2024)
11.12.5 Novartis Recent Development
11.13 Astellas
11.13.1 Astellas Company Detail
11.13.2 Astellas Business Overview
11.13.3 Astellas Diabetes Care Drugs Introduction
11.13.4 Astellas Revenue in Diabetes Care Drugs Business (2019-2024)
11.13.5 Astellas Recent Development
11.14 Teva
11.14.1 Teva Company Detail
11.14.2 Teva Business Overview
11.14.3 Teva Diabetes Care Drugs Introduction
11.14.4 Teva Revenue in Diabetes Care Drugs Business (2019-2024)
11.14.5 Teva Recent Development
11.15 Bayer
11.15.1 Bayer Company Detail
11.15.2 Bayer Business Overview
11.15.3 Bayer Diabetes Care Drugs Introduction
11.15.4 Bayer Revenue in Diabetes Care Drugs Business (2019-2024)
11.15.5 Bayer Recent Development
11.16 Ganlee
11.16.1 Ganlee Company Detail
11.16.2 Ganlee Business Overview
11.16.3 Ganlee Diabetes Care Drugs Introduction
11.16.4 Ganlee Revenue in Diabetes Care Drugs Business (2019-2024)
11.16.5 Ganlee Recent Development
11.17 Ginwa
11.17.1 Ginwa Company Detail
11.17.2 Ginwa Business Overview
11.17.3 Ginwa Diabetes Care Drugs Introduction
11.17.4 Ginwa Revenue in Diabetes Care Drugs Business (2019-2024)
11.17.5 Ginwa Recent Development
11.18 MSD
11.18.1 MSD Company Detail
11.18.2 MSD Business Overview
11.18.3 MSD Diabetes Care Drugs Introduction
11.18.4 MSD Revenue in Diabetes Care Drugs Business (2019-2024)
11.18.5 MSD Recent Development
11.19 Hisun Pharmacy
11.19.1 Hisun Pharmacy Company Detail
11.19.2 Hisun Pharmacy Business Overview
11.19.3 Hisun Pharmacy Diabetes Care Drugs Introduction
11.19.4 Hisun Pharmacy Revenue in Diabetes Care Drugs Business (2019-2024)
11.19.5 Hisun Pharmacy Recent Development
11.20 Huadong Medicine
11.20.1 Huadong Medicine Company Detail
11.20.2 Huadong Medicine Business Overview
11.20.3 Huadong Medicine Diabetes Care Drugs Introduction
11.20.4 Huadong Medicine Revenue in Diabetes Care Drugs Business (2019-2024)
11.20.5 Huadong Medicine Recent Development
11.21 Jumpcan Pharmacy
11.21.1 Jumpcan Pharmacy Company Detail
11.21.2 Jumpcan Pharmacy Business Overview
11.21.3 Jumpcan Pharmacy Diabetes Care Drugs Introduction
11.21.4 Jumpcan Pharmacy Revenue in Diabetes Care Drugs Business (2019-2024)
11.21.5 Jumpcan Pharmacy Recent Development
11.22 KELUN
11.22.1 KELUN Company Detail
11.22.2 KELUN Business Overview
11.22.3 KELUN Diabetes Care Drugs Introduction
11.22.4 KELUN Revenue in Diabetes Care Drugs Business (2019-2024)
11.22.5 KELUN Recent Development
11.23 North China Pharmaceutical Group Corporation
11.23.1 North China Pharmaceutical Group Corporation Company Detail
11.23.2 North China Pharmaceutical Group Corporation Business Overview
11.23.3 North China Pharmaceutical Group Corporation Diabetes Care Drugs Introduction
11.23.4 North China Pharmaceutical Group Corporation Revenue in Diabetes Care Drugs Business (2019-2024)
11.23.5 North China Pharmaceutical Group Corporation Recent Development
11.24 Taloph
11.24.1 Taloph Company Detail
11.24.2 Taloph Business Overview
11.24.3 Taloph Diabetes Care Drugs Introduction
11.24.4 Taloph Revenue in Diabetes Care Drugs Business (2019-2024)
11.24.5 Taloph Recent Development
11.25 Tianan Pharmaceutical
11.25.1 Tianan Pharmaceutical Company Detail
11.25.2 Tianan Pharmaceutical Business Overview
11.25.3 Tianan Pharmaceutical Diabetes Care Drugs Introduction
11.25.4 Tianan Pharmaceutical Revenue in Diabetes Care Drugs Business (2019-2024)
11.25.5 Tianan Pharmaceutical Recent Development
11.26 Tonghua DongBao
11.26.1 Tonghua DongBao Company Detail
11.26.2 Tonghua DongBao Business Overview
11.26.3 Tonghua DongBao Diabetes Care Drugs Introduction
11.26.4 Tonghua DongBao Revenue in Diabetes Care Drugs Business (2019-2024)
11.26.5 Tonghua DongBao Recent Development
11.27 Wanbang Biopharmaceuticals
11.27.1 Wanbang Biopharmaceuticals Company Detail
11.27.2 Wanbang Biopharmaceuticals Business Overview
11.27.3 Wanbang Biopharmaceuticals Diabetes Care Drugs Introduction
11.27.4 Wanbang Biopharmaceuticals Revenue in Diabetes Care Drugs Business (2019-2024)
11.27.5 Wanbang Biopharmaceuticals Recent Development
11.28 Takeda
11.28.1 Takeda Company Detail
11.28.2 Takeda Business Overview
11.28.3 Takeda Diabetes Care Drugs Introduction
11.28.4 Takeda Revenue in Diabetes Care Drugs Business (2019-2024)
11.28.5 Takeda Recent Development
11.29 SHIJIAZHUANG YILING PHARMACEUTICAL
11.29.1 SHIJIAZHUANG YILING PHARMACEUTICAL Company Detail
11.29.2 SHIJIAZHUANG YILING PHARMACEUTICAL Business Overview
11.29.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Care Drugs Introduction
11.29.4 SHIJIAZHUANG YILING PHARMACEUTICAL Revenue in Diabetes Care Drugs Business (2019-2024)
11.29.5 SHIJIAZHUANG YILING PHARMACEUTICAL Recent Development
11.30 Guangzhou Baiyun Mountain
11.30.1 Guangzhou Baiyun Mountain Company Detail
11.30.2 Guangzhou Baiyun Mountain Business Overview
11.30.3 Guangzhou Baiyun Mountain Diabetes Care Drugs Introduction
11.30.4 Guangzhou Baiyun Mountain Revenue in Diabetes Care Drugs Business (2019-2024)
11.30.5 Guangzhou Baiyun Mountain Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Diabetes Care Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral Anti-diabetic Drugs
Table 3. Key Players of Insulins
Table 4. Key Players of Non-insulin Injectable Drugs
Table 5. Key Players of Other
Table 6. Global Diabetes Care Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Diabetes Care Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Diabetes Care Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Diabetes Care Drugs Market Share by Region (2019-2024)
Table 10. Global Diabetes Care Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Diabetes Care Drugs Market Share by Region (2025-2030)
Table 12. Diabetes Care Drugs Market Trends
Table 13. Diabetes Care Drugs Market Drivers
Table 14. Diabetes Care Drugs Market Challenges
Table 15. Diabetes Care Drugs Market Restraints
Table 16. Global Diabetes Care Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Diabetes Care Drugs Market Share by Players (2019-2024)
Table 18. Global Top Diabetes Care Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Care Drugs as of 2023)
Table 19. Ranking of Global Top Diabetes Care Drugs Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Diabetes Care Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Diabetes Care Drugs Product Solution and Service
Table 23. Date of Enter into Diabetes Care Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Diabetes Care Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Diabetes Care Drugs Revenue Market Share by Type (2019-2024)
Table 27. Global Diabetes Care Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Diabetes Care Drugs Revenue Market Share by Type (2025-2030)
Table 29. Global Diabetes Care Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Diabetes Care Drugs Revenue Market Share by Application (2019-2024)
Table 31. Global Diabetes Care Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Diabetes Care Drugs Revenue Market Share by Application (2025-2030)
Table 33. North America Diabetes Care Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Diabetes Care Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Diabetes Care Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Diabetes Care Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Diabetes Care Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Diabetes Care Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Diabetes Care Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Diabetes Care Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Diabetes Care Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Diabetes Care Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Diabetes Care Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Diabetes Care Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Diabetes Care Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Diabetes Care Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Diabetes Care Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. Novo Nordisk Company Detail
Table 49. Novo Nordisk Business Overview
Table 50. Novo Nordisk Diabetes Care Drugs Product
Table 51. Novo Nordisk Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 52. Novo Nordisk Recent Development
Table 53. Sanofi Company Detail
Table 54. Sanofi Business Overview
Table 55. Sanofi Diabetes Care Drugs Product
Table 56. Sanofi Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 57. Sanofi Recent Development
Table 58. Eli Lilly Company Detail
Table 59. Eli Lilly Business Overview
Table 60. Eli Lilly Diabetes Care Drugs Product
Table 61. Eli Lilly Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 62. Eli Lilly Recent Development
Table 63. Biocon Company Detail
Table 64. Biocon Business Overview
Table 65. Biocon Diabetes Care Drugs Product
Table 66. Biocon Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 67. Biocon Recent Development
Table 68. AstraZeneca Company Detail
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Diabetes Care Drugs Product
Table 71. AstraZeneca Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 72. AstraZeneca Recent Development
Table 73. Bristol Myers Squibb Company Detail
Table 74. Bristol Myers Squibb Business Overview
Table 75. Bristol Myers Squibb Diabetes Care Drugs Product
Table 76. Bristol Myers Squibb Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 77. Bristol Myers Squibb Recent Development
Table 78. Boehringer Ingelheim Company Detail
Table 79. Boehringer Ingelheim Business Overview
Table 80. Boehringer Ingelheim Diabetes Care Drugs Product
Table 81. Boehringer Ingelheim Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 82. Boehringer Ingelheim Recent Development
Table 83. Mylan Company Detail
Table 84. Mylan Business Overview
Table 85. Mylan Diabetes Care Drugs Product
Table 86. Mylan Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 87. Mylan Recent Development
Table 88. Pfizer Company Detail
Table 89. Pfizer Business Overview
Table 90. Pfizer Diabetes Care Drugs Product
Table 91. Pfizer Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. Johnson & Johnson Company Detail
Table 94. Johnson & Johnson Business Overview
Table 95. Johnson & Johnson Diabetes Care Drugs Product
Table 96. Johnson & Johnson Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 97. Johnson & Johnson Recent Development
Table 98. Merck Company Detail
Table 99. Merck Business Overview
Table 100. Merck Diabetes Care Drugs Product
Table 101. Merck Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 102. Merck Recent Development
Table 103. Novartis Company Detail
Table 104. Novartis Business Overview
Table 105. Novartis Diabetes Care Drugs Product
Table 106. Novartis Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 107. Novartis Recent Development
Table 108. Astellas Company Detail
Table 109. Astellas Business Overview
Table 110. Astellas Diabetes Care Drugs Product
Table 111. Astellas Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 112. Astellas Recent Development
Table 113. Teva Company Detail
Table 114. Teva Business Overview
Table 115. Teva Diabetes Care Drugs Product
Table 116. Teva Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 117. Teva Recent Development
Table 118. Bayer Company Detail
Table 119. Bayer Business Overview
Table 120. Bayer Diabetes Care Drugs Product
Table 121. Bayer Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 122. Bayer Recent Development
Table 123. Ganlee Company Detail
Table 124. Ganlee Business Overview
Table 125. Ganlee Diabetes Care Drugs Product
Table 126. Ganlee Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 127. Ganlee Recent Development
Table 128. Ginwa Company Detail
Table 129. Ginwa Business Overview
Table 130. Ginwa Diabetes Care Drugs Product
Table 131. Ginwa Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 132. Ginwa Recent Development
Table 133. MSD Company Detail
Table 134. MSD Business Overview
Table 135. MSD Diabetes Care Drugs Product
Table 136. MSD Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 137. MSD Recent Development
Table 138. Hisun Pharmacy Company Detail
Table 139. Hisun Pharmacy Business Overview
Table 140. Hisun Pharmacy Diabetes Care Drugs Product
Table 141. Hisun Pharmacy Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 142. Hisun Pharmacy Recent Development
Table 143. Huadong Medicine Company Detail
Table 144. Huadong Medicine Business Overview
Table 145. Huadong Medicine Diabetes Care Drugs Product
Table 146. Huadong Medicine Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 147. Huadong Medicine Recent Development
Table 148. Jumpcan Pharmacy Company Detail
Table 149. Jumpcan Pharmacy Business Overview
Table 150. Jumpcan Pharmacy Diabetes Care Drugs Product
Table 151. Jumpcan Pharmacy Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 152. Jumpcan Pharmacy Recent Development
Table 153. KELUN Company Detail
Table 154. KELUN Business Overview
Table 155. KELUN Diabetes Care Drugs Product
Table 156. KELUN Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 157. KELUN Recent Development
Table 158. North China Pharmaceutical Group Corporation Company Detail
Table 159. North China Pharmaceutical Group Corporation Business Overview
Table 160. North China Pharmaceutical Group Corporation Diabetes Care Drugs Product
Table 161. North China Pharmaceutical Group Corporation Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 162. North China Pharmaceutical Group Corporation Recent Development
Table 163. Taloph Company Detail
Table 164. Taloph Business Overview
Table 165. Taloph Diabetes Care Drugs Product
Table 166. Taloph Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 167. Taloph Recent Development
Table 168. Tianan Pharmaceutical Company Detail
Table 169. Tianan Pharmaceutical Business Overview
Table 170. Tianan Pharmaceutical Diabetes Care Drugs Product
Table 171. Tianan Pharmaceutical Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 172. Tianan Pharmaceutical Recent Development
Table 173. Tonghua DongBao Company Detail
Table 174. Tonghua DongBao Business Overview
Table 175. Tonghua DongBao Diabetes Care Drugs Product
Table 176. Tonghua DongBao Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 177. Tonghua DongBao Recent Development
Table 178. Wanbang Biopharmaceuticals Company Detail
Table 179. Wanbang Biopharmaceuticals Business Overview
Table 180. Wanbang Biopharmaceuticals Diabetes Care Drugs Product
Table 181. Wanbang Biopharmaceuticals Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 182. Wanbang Biopharmaceuticals Recent Development
Table 183. Takeda Company Detail
Table 184. Takeda Business Overview
Table 185. Takeda Diabetes Care Drugs Product
Table 186. Takeda Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 187. Takeda Recent Development
Table 188. SHIJIAZHUANG YILING PHARMACEUTICAL Company Detail
Table 189. SHIJIAZHUANG YILING PHARMACEUTICAL Business Overview
Table 190. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Care Drugs Product
Table 191. SHIJIAZHUANG YILING PHARMACEUTICAL Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 192. SHIJIAZHUANG YILING PHARMACEUTICAL Recent Development
Table 193. Guangzhou Baiyun Mountain Company Detail
Table 194. Guangzhou Baiyun Mountain Business Overview
Table 195. Guangzhou Baiyun Mountain Diabetes Care Drugs Product
Table 196. Guangzhou Baiyun Mountain Revenue in Diabetes Care Drugs Business (2019-2024) & (US$ Million)
Table 197. Guangzhou Baiyun Mountain Recent Development
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Care Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Diabetes Care Drugs Market Share by Type: 2023 VS 2030
Figure 3. Oral Anti-diabetic Drugs Features
Figure 4. Insulins Features
Figure 5. Non-insulin Injectable Drugs Features
Figure 6. Other Features
Figure 7. Global Diabetes Care Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Diabetes Care Drugs Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Medical Research Institute Case Studies
Figure 11. Clinic Case Studies
Figure 12. Other Case Studies
Figure 13. Diabetes Care Drugs Report Years Considered
Figure 14. Global Diabetes Care Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Diabetes Care Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Diabetes Care Drugs Market Share by Region: 2023 VS 2030
Figure 17. Global Diabetes Care Drugs Market Share by Players in 2023
Figure 18. Global Top Diabetes Care Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Care Drugs as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Diabetes Care Drugs Revenue in 2023
Figure 20. North America Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Diabetes Care Drugs Market Share by Country (2019-2030)
Figure 22. United States Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Diabetes Care Drugs Market Share by Country (2019-2030)
Figure 26. Germany Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Diabetes Care Drugs Market Share by Region (2019-2030)
Figure 34. China Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Diabetes Care Drugs Market Share by Country (2019-2030)
Figure 42. Mexico Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Diabetes Care Drugs Market Share by Country (2019-2030)
Figure 46. Turkey Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Diabetes Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Novo Nordisk Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 49. Sanofi Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 50. Eli Lilly Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 51. Biocon Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 52. AstraZeneca Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 53. Bristol Myers Squibb Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 54. Boehringer Ingelheim Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 55. Mylan Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 56. Pfizer Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 57. Johnson & Johnson Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 58. Merck Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 59. Novartis Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 60. Astellas Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 61. Teva Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 62. Bayer Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 63. Ganlee Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 64. Ginwa Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 65. MSD Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 66. Hisun Pharmacy Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 67. Huadong Medicine Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 68. Jumpcan Pharmacy Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 69. KELUN Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 70. North China Pharmaceutical Group Corporation Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 71. Taloph Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 72. Tianan Pharmaceutical Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 73. Tonghua DongBao Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 74. Wanbang Biopharmaceuticals Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 75. Takeda Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 76. SHIJIAZHUANG YILING PHARMACEUTICAL Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 77. Guangzhou Baiyun Mountain Revenue Growth Rate in Diabetes Care Drugs Business (2019-2024)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock